MU
Micron Technology, Inc.
MU has the edge over TRT overall, supported by stronger valuation and stronger modeled upside.
TRT
Trio-Tech International
TRT trails on the overall score without a compensating advantage in the available component scores.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
TRT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
TRT's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over TRT in the historical PE scenario, which offers more potential upside but is not a forecast.
TRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $0.56 | -90% |
| Fair | 24x | $1.46 | -74% |
| Expensive | 47x | $2.81 | -50% |
| Current | 93x | $5.60 | — |
Historical ranges are pointers, not guarantees.
TRT's PE is in its expensive range at 93x.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
TRT Forward outlook
There aren't enough analyst estimates for TRT to show an outlook.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over TRT on earnings, with more consistent year-over-year improvement.
TRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.06 | +100% |
| Q2 2026 | $0.00 | +$0.01 |
| Q1 2026 | $0.04 | +$0.05 |
| Q4 2025 | -$0.01 | -117% |
| Q3 2025 | $0.03 | -50% |
| Q2 2025 | -$0.01 | -108% |
| Q1 2025 | -$0.01 | -108% |
| Q4 2024 | $0.06 | -45% |
TRT's earnings per share have fallen from their peak: $0.06 over the past year, against $0.28 in mid-2022.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over TRT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over TRT on profitability, with a higher operating margin.
TRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.9M | +29% |
| Q2 2026 | $14.9M | +40% |
| Q1 2026 | $16.5M | +124% |
| Q4 2025 | $15.6M | +82% |
| Q3 2025 | $15.5M | +58% |
| Q2 2025 | $10.7M | +9.5% |
| Q1 2025 | $7.4M | -29% |
| Q4 2024 | $8.6M | -29% |
TRT's revenue has grown year over year for six quarters in a row: $20M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +6 points |
| Q2 2026 | -1.8% | -6.2 points |
| Q1 2026 | -0.5% | +4.2 points |
| Q4 2025 | 0.6% | +0.7 points |
| Q3 2025 | 0.3% | -1.1 points |
| Q2 2025 | 4.4% | +0.7 points |
| Q1 2025 | -4.7% | -5.2 points |
| Q4 2024 | 0% | -5.6 points |
TRT's operating margin was 6.3% last quarter, up 6 points from the same quarter a year ago.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over TRT on cash generation, producing positive trailing cash flow while its opponent burns cash.
TRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.1M | -567% |
| Q2 2026 | $244K | +$1.5M |
| Q1 2026 | $707K | +13% |
| Q4 2025 | -$152K | -108% |
| Q3 2025 | $887K | +$2.8M |
| Q2 2025 | -$1.2M | -$932K |
| Q1 2025 | $623K | -48% |
| Q2 2024 | -$289K | -123% |
TRT's free cash flow was −$3M over the past year, against $2M the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over TRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
TRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +2.4M shares |
| 1 year | +31% | +2.7M shares |
| 3 years | +33% | +2.8M shares |
| 5 years | +42% | +3.4M shares |
TRT has 11M diluted shares, up 31% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $63,000 |
| Q2 2026 | — |
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
TRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.9x | Net Cash |
| Q2 2026 | -10.1x | Net Cash |
| Q1 2026 | -4.5x | Net Cash |
| Q4 2025 | -4.6x | Net Cash |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -3.4x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
TRT has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
TRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 7.5 | Oversold |
TRT's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over TRT on valuation relative to its sector.
TRT PE vs Technology Sector
| Metric | TRT | Sector median | Relative |
|---|---|---|---|
| PE | 93x | 28x | 235% above |
| PE % | 88 | 35 | 53 pts above |
TRT is trading at 93x earnings, a 235% premium to the Technology sector's median of 28x.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over TRT on trend strength, trading above more of its moving averages.
TRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 3.7% above |
| 20 week MA | $8.43 | 34% below |
| 50 week MA | $8.47 | 34% below |
| 100 week MA | $5.72 | 2.1% below |
| 200 week MA | $4.29 | 31% above |
TRT's trend is mixed: it's above two of its five weekly moving averages, and 31% above its 200-week average.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over TRT on returns for 2026, with the stronger performance.
TRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.11 | $1.96 | -7.1% |
| 2021 | $1.96 | $6.27 | +220% |
| 2022 | $6.27 | $2.29 | -63% |
| 2023 | $2.29 | $2.54 | +11% |
| 2024 | $2.54 | $2.96 | +17% |
| 2025 | $2.96 | $7.00 | +136% |
| 2026 YTD | $7.00 | $5.60 | -20% |
TRT's yearly returns have swung widely, from +220% in 2021 to −63% in 2022. It's down 20% so far in 2026.